Measurable disease per FET-PET vs MRI in GBM episode artwork

EPISODE · Feb 8, 2025 · 14 MIN

Measurable disease per FET-PET vs MRI in GBM

from Neuro-Oncology: The Podcast · host Dr. Iyad Alnahhas, Dr. Nathalie Albert

Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments", published online in Neuro-Oncology in January 2025.

NOW PLAYING

Measurable disease per FET-PET vs MRI in GBM

0:00 14:06

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 14 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on February 8, 2025.

What is this episode about?

Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments",...

Can I download this Neuro-Oncology: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!